Clearance of a fluconazole-resistant Candida albicans strain after switching antifungal therapy and initiation of triple therapy for HIV infection

Clinical Microbiology and Infection

Volumn 6, Issue 4, 2000, Pages 220-223

  Ruhnke, M ^a   Adlerand, A ^a   Muller F M ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CYCLODEXTRIN; DIDANOSINE; FLUCONAZOLE; FUNGAL DNA; ITRACONAZOLE; LAMIVUDINE; NEVIRAPINE; PROTEINASE INHIBITOR; SAQUINAVIR; STAVUDINE; VIRUS RNA; ZIDOVUDINE;

ADULT; AIDS RELATED COMPLEX; ARTICLE; CANDIDA ALBICANS; CASE REPORT; DNA FINGERPRINTING; DNA HYBRIDIZATION; DRUG EFFICACY; DRUG SENSITIVITY; FUNGAL STRAIN; FUNGUS CULTURE; FUNGUS ISOLATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; THRUSH; VIRUS LOAD;

CANDIDA; CANDIDA ALBICANS; FUNGI; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0034174716     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2000.00041-1.x     Document Type: Article

References (11)

1. Infection due to fluconazole-resistant Candida in patients with AIDS. Prevalence and microbiology
2. Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir
3. Comparative evaluation of three antifungal susceptibility test methods for Candida albicans isolates and correlation with response to fluconazole therapy
4. Molecular epidemiology of Candida isolates from AIDS patients showing different fluconazole resistance profiles
5. Candida dubliniensis sp. nov.: Phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals
6. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel
7. Decreasing incidence of oropharyngeal candidiasis in an HIV cohort following the introduction of proteinase inhibitors
8. Effect of highly active antiretroviral therapy on recurrent oropharyngeal candidiasis in HIV-infected patients
9. Itraconazole cyclodextrin solution-effective treatment for HIV-related candidosis unresponsive to other azole therapy
10. Itraconazole cyclodextrin solution for fluconazole-refractory oropharyngeal candidiasis in AIDS: Correlation of clinical response with in vitro susceptibility
11. Oropharyngeal and esophageal candidiasis in immunocompromised patients: Treatment issues